SCHEMBL14701587

SCHEMBL14701587

Cc1cccc(C)c1-n1cnc(C(C)C)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.37
ALDH1A1 P00352 2/20 0.37
ALOX15 P16050 1/20 0.37
GRM5 P41594 5/20 0.35
GRM1 Q13255 3/20 0.35
CYP2E1 P05181 1/20 0.33
CYP2A6 P11509 1/20 0.33
HCAR1 Q9BXC0 1/20 0.33
NPSR1 Q6W5P4 1/20 0.32
MAP3K5 Q99683 3/20 0.31
CPB1 P15086 1/20 0.31
CPB2 Q96IY4 1/20 0.31
TYMS P04818 1/20 0.30
SCN4A P35499 3/20 0.30
LMNA P02545 1/20 0.30
CYP1A2 P05177 1/20 0.30
CYP3A4 P08684 1/20 0.30
CYP2D6 P10635 1/20 0.30
CYP2C9 P11712 1/20 0.30
NFKB1 P19838 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14704080 0.77 CYP2E1 (0.49) TSHRALDH1A1CYP2E1CYP2A6HCAR1
SCHEMBL13341971 0.75 KDM4E (0.56) ALDH1A1CPB2CYP1A2CYP3A4
SCHEMBL12443627 0.74 CYP2E1 (0.42) ALDH1A1GRM5GRM1CYP2E1CYP2A6
SCHEMBL13183612 0.73 CYP1A2 (0.38) TSHRALOX15GRM5GRM1CYP2E1
SCHEMBL11046359 0.71 CPB1 (0.39) TSHRALDH1A1GRM5GRM1HCAR1
SCHEMBL22185839 0.70 CPB2 (0.44) ALDH1A1GRM5CPB1CPB2
SCHEMBL22185260 0.70 HTR3E (0.41) TSHRALDH1A1ALOX15GRM5GRM1
SCHEMBL13659754 0.70 KDM4E (0.38) ALDH1A1GRM5GRM1CPB1CPB2
SCHEMBL21668008 0.70 KDM2B (0.48) HCAR1NPSR1
SCHEMBL24495988 0.69 CYP2E1 (0.41) GRM5GRM1CYP2E1CYP2A6CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9284350-B2 IAP BIR domain binding compounds PHARMASCIENCE INC. (CA) 2016-03-15 US disclosed
US-20130040892-A1 IAP BIR DOMAIN BINDING COMPOUNDS PHARMASCIENCE INC. (CA) 2013-02-14 US disclosed
US-20130040892-A1 IAP BIR DOMAIN BINDING COMPOUNDS PHARMASCIENCE INC. (CA) 2013-02-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130040892-A1 IAP BIR DOMAIN BINDING COMPOUNDS BIRC5, BIRC2, BIRC3 TSHR 4828/4885ALDH1A1 4122/4885ALOX15 3323/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.